What is it about?
We examined whether the hub and spoke care model is associated with increased use of medication for opioid use disorder for all racial and ethnic groups in this Washington State sample. We found medication treatment use increase for increased significantly for Black, Hispanic, and White enrollees in the hub and spoke cohort, compared to enrollees of the same race and ethnicity not treated in the hub and spoke model. Methadone use increased significantly among American Indian and Alaskan Native enrollees in the hub and spoke group but buprenorphine use did not.
Featured Image
Read the Original
This page is a summary of: Differential Changes in Use of Medications for Opioid Use Disorder by Race-Ethnicity: Effects of a Hub-and-Spoke Model, Psychiatric Services, September 2025, American Psychiatric Association,
DOI: 10.1176/appi.ps.20240373.
You can read the full text:
Contributors
The following have contributed to this page







